openPR Logo
Press release

Strategic Competitive Intelligence and the role of the Microbiome in Immuno-Oncology

06-07-2018 10:40 AM CET | Health & Medicine

Press release from: SMi Group

Strategic Competitive Intelligence and the role of

In addition to the Main Conference’s agenda (covering a breadth of topics and presentations ranging from case studies about Keytruda therapies to keynote addresses exploring the tumour mutation burden), SMi Group is pleased to have the expertise of the industry leaders leading on-site interactive training programmes. By attending these half-day workshops, on the 25 September, attendees will formulate a deeper understanding of Strategic Competitive Intelligence and the role of the Microbiome in Immuno-Oncology.

Workshop A, 25 September, 8.30 - 12.30 - Strategic competitive intelligence in the Immuno-Oncology space
• Uncover opportunities and threats for your company and brand in the Immuno-Oncology space by combining the latest advancements in Strategic Competitive Intelligence.
• Get step-by-step guide on how to use CI to generate actionable insights and gain a competitive advantage over others.
This workshop is led by: Timos Papagatsias, CEO of LucidQuest - an expert with over 10 years’ experience working as a strategy and intelligence consultant across the Pharma / Biotech and the Life Sciences Investment industries. Timos is now leading LucidQuest, a boutique strategic intelligence consultancy that focuses both on traditional therapy areas (oncology, haematology, immunology, CV/Met, CNS etc.) as well as on developing insights into patient centricity, digital healthcare / IoE and personalized medicine (gene and cell therapies).

Workshop B, 25 September, 13.30 - 17.00 - Could the Microbiome boost Cancer Immuno-Therapy
• Further the knowledge in the advantages and challenges of developing microbiome-based treatments by looking into recent advances in understanding of the complex role of microbiome in health and disease and how microbes and the microbiota may contribute to cancer development, and responsiveness to cancer therapeutics.
This workshop is led by:
• Shahram Lavasani, CEO of ImmuneBiotech AB - skilful immunologist and PhD holder in Medical Inflammation Research. Now leading ImmuneBiotech, Shahram developed a proprietary lactobacilli library and established accurate and multiple selection technologies to screen and design formulations for the optimal therapeutic management of the diseases.
• Ramin Massoumi, Associate Professor at Lund University, working on research into molecular targeted therapy [1]

Further details at http://www.immuno-oncology-conference.com/openpr

Twitter - @SMIpharm & #immunooncologysmi
LinkedIn - SMi Pharma

CONTACT:
+44 (0)20 7827 6000
ldurneva@smi-online.co.uk

[1] portal.research.lu.se/portal/en/persons/ramin-massoumi(ecd19c7b-c3a4-414d-a686-8bf643504064).html

About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

SMi Group Ltd
1 Westminster Bridge Rd, South Bank, London SE1 7XW
Lyudmyla Durneva
ldurneva@smi-online.co.uk

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Strategic Competitive Intelligence and the role of the Microbiome in Immuno-Oncology here

News-ID: 1073845 • Views: 728

More Releases from SMi Group

Conference Chair from AstraZeneca invites you to attend Pre-filled Syringes East …
The 7th annual Pre-filled Syringes East Coast conference and exhibition is returning to Boston USA, in April. SMi Group are delighted to have Michael Song, Senior Manager, Dosage Form Design and Development, AstraZeneca chairing the two-day conference. Read the letter from the chair: Dear Colleagues, It is with great pleasure and delight that we welcome each of you to SMi's 7th annual Pre-Filled Syringes East conference in Boston, USA. Over the past decade, the
Registration Opens for Future Armoured Vehicles Weapon Systems 2020
SMi Group are pleased to announce the return of the Future Armoured Vehicles Weapon Systems conference, which will convene in London on the 3rd - 4th June 2020 for its fifth year. High level military personnel and industry leaders from around the globe will gather to gain insight on the latest developments in firepower capabilities and weapon systems for next generation armoured vehicles. Industry experts will provide an overview of cutting-edge
Estonian Defence Forces to give updates on their RAS Program at Military Robotic …
The 3rd Annual Military Robotics and Autonomous Systems (RAS) Conference, taking place on the 1st-2nd April 2020 in London, will provide essential insights into the development and implementation of unmanned and autonomous ground systems from the world's leading militaries. For those who would like to attend the conference, there is a 100 GBP early bird discount for bookings made by 28th February 2020. Register online at http://www.robotics-autonomous.com/openpr5
AI in Drug Discovery to host panel discussion on "The AI Paradigm Shift - is it …
SMi Reports: The AI in Drug Discovery conference will feature a panel discussion with panellists from Novartis, OMass Therapeutics, Domaineux and AstraZeneca. SMi Group's inaugural AI in Drug Discovery conference will take place on 16th-17th March 2020 in London to analyse and discuss AI machine learning technologies and their potential to reduce drug discovery costs by an estimated US$70 billion over the next decade. The conference will host a panel discussion

All 5 Releases


More Releases for Strategic

Ethiopia’s strategic cooperation with China
Over the past decade, Ethiopia has experienced an average economic growth rate of about 10%. Ethiopia is expected to grow by 8.5% in 2018, topping China’s projected growth of 6.5%. In recent times, the Ethiopian government has abandoned its 1970’s Communist ideology and put in place some basic reforms. They went on to build sturdy infrastructure and launch a successful industrial policy, calling to mind China’s own development pathway. The Chinese have
Strategic Analysis Of Diethylenetriamine Market
Diethylenetriamine, also abbreviated as DETA serves as an organic compound. It is a colorless hygroscopic liquid which is soluble in polar organic solvents and water, but not simple hydrocarbons. DETA is the structural analogue of diethylene glycol, with chemical properties resembling to those of ethylene diamine with similar uses. Diethylenetriamine is a byproduct which is formed from manufacturing ethylene diamine from ethylene dichloride. DETA is used in a wide range
India and Japan’s strategic alliance
Indian Prime Minister Narendra Modi along with Japanese Prime Minister Shinzo Abe agreed to work on an open Indo-Pacific region strategy with cooperation in infrastructure development and maritime security. The Japanese government will pump in more investment into high-quality railway and road network projects. Can a strategic alliance between Japan and India help in maintaining a stable regional balance of power, given the current stance of the US? Find out more here: https://www.spireresearch.com/newsroom/spirethoughts/india-and-japans-strategic-alliance/ Spire
Strategic Analysis of Waterstops Market
Waterstops are flexible seals installed in concrete structures to prevent the passage of fluids between joints of concrete structures. They are designed as a fluid tight diaphragm. They play an important role in waterproofing concrete structures, especially joints and the weakest areas which are prone to leakage of fluids. Concrete contracts and expands with temperature fluctuations. Waterstops are installed in order to cope up with the changes. Joints unless sealed
Strategic Analysis of Ethanol Market
The global ethanol market is characterized by the prominent presence of companies such as Solvay Group, Flint Hill Resources, LP, POET, LLC, Valero Energy Corporation, The Andersons, Inc., Green Plains, Inc., Pacific Ethanol, Inc., Mitsubishi Chemical Corporation, Cargill, Incorporated, and Archer-Daniels-Midland Company, finds Transparency Market Research (TMR). Players strive to tap on vast lucrative opportunities arising out of the burgeoning demand from several end-use industries, notably automobile and alcoholic beverages.
Strategic Strengthening of Arvato Systems
Arvato IT service business to be further focused on growth - Arvato Systems remains top IT service provider for B2B customers - Additional role as a strategic IT partner for Arvato and Bertelsmann - New management from 1 April: CEO Matthias Moeller - Arvato CEO Fernando Carro: “We are investing in the IT business. The new strategy will enable Arvato Systems to exploit new growth opportunities.” Gütersloh – The international services company Arvato is strengthening